Alpa Laboratories
ALPANSE

Alpa Laboratories

₹62.750.65 (1.05%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
62.00
Today’s high
64.50
52 week low
46.10
52 week high
101.00
Open price
63.36
Previous close
62.10
Live volume
6,628
Lower circuit
50.20
Upper circuit
75.30

Fundamentals

Market Cap
₹131Cr
ROE
8.06%
P/E Ratio(TTM)
32.23
EPS(TTM)
1.93
P/B Ratio
0.70
Dividend Yield
0.00%
Industry P/E
37.23
Book Value
88.53
Debt to Equity
0.01
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹29.70
-4.93%
Profit (Cr)
₹0.98
-28.99%
010203040
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)-4%
3Y CAGR+3%
Profit growthValue
1Y (TTM)-92%
3Y CAGR+11%

About

Alpa Laboratories Limited is a global pharmaceutical firm committed to improving health outcomes for patients around the world by manufacturing best-quality medicines. The company makes substantial investments in branded generic products, leveraging its specialized knowledge to expand its footprint in critical markets across the globe. Its strong financial position enables the organization to fund innovative solutions that are specifically designed to address the evolving needs of patients. A core part of its mission, established since 1988, is to continuously enhance operational performance to successfully introduce new and effective medicines. The company's philosophy prioritizes long-term sustainable growth and creating lasting value by emphasizing transparency, accountability, and integrity in all operations. Reflecting its successful strategy, the company achieved a notable 20.70% growth in standalone total income in the most recent financial year.;
CEO/MD
Paresh Chawla
Founded in
1988
NSE symbol
ALPA

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,978.20
+58.20 (1.18%)
L
    H
    22,514.2930.625.36
    ₹2,560.80
    +31.10 (1.23%)
    L
      H
      19,234.0028.375.36
      ₹7,415.50
      -91.50 (1.22%)
      L
        H
        18,760.75110.621.5
        Natco PharmaNATCOPHARM
        ₹882.40
        +4.90 (0.56%)
        L
          H
          15,721.3713.731.7
          2026
          14
          Aug
          Quarterly Result
          Release date
          29
          May
          Annual Result
          Release date
          11
          Feb
          Quarterly Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks